Initial containment plan and non-pharmacological measures adopted by Brazilian states at the beginning of the covid-19 pandemic

Authors

  • Marli Terezinha Stein Backes Universidade Federal de Santa Catarina
  • Maria Vitória de Azeredo Knoblauch Sem registro de afiliação
  • Samanta Felippe Will Sem registro de afiliação

DOI:

https://doi.org/10.14201/reb20241123185200

Keywords:

Biological risk containment, COVID-19, fatal outcome, SARS-CoV-2, infectious disease transmission

Abstract

The purpose of this text is to survey the initial containment plan for COVID-19 and the first non-pharmaceutical measures adopted in different Brazilian regions and states at the beginning of the pandemic. The methodology is documentary research, which involved gathering information from official state websites, state health departments, and state attorney general offices. The first decrees issued at the start of the COVID-19 pandemic in Brazil were used, as they portray the “first decisions” at the state level. The data were analyzed through content analysis. From the emergence of the first COVID-19 cases in the country, the 27 Brazilian states instituted, between February and June 2020, through various decrees, non-pharmaceutical and immediate restrictive measures related to commercial, educational, sports, cultural, religious, and scientific activities, generally maintaining only services considered essential, such as health institutions and services, pharmacies, supermarkets, gas stations, basic sanitation, among others. In this sense, the restrictive measures adopted were of great importance and contributed to building hospital-level healthcare capacity, with some regional differences.

Downloads

Download data is not yet available.

Author Biography

  • Marli Terezinha Stein Backes, Universidade Federal de Santa Catarina

    Professor in the Graduate Program in Nursing at the Universidade Federal de Santa Catarina (UFSC, Brazil).

References

Brasil. Coronavírus // Brasil. (2023, 05, jan.). Covid-19: painel coronavírus. Atualizado em 04/01/2023 16:55. Recuperado em 05 de janeiro de 2023, de https://covid.saude.gov.br/.

Buss, L. F., Prete Jr, C. A., Abrahim, C. M. M., Mendrone Jr, A., Salomon, T., Almeida-Neto, C., et al. (2021). Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science, 371(6526), 288-292.

Candido, D. S., Claro, I. M., Jesus, J. G., Souza, W. M., Moreira, F. R. R., Dellicour, S., et al. (2020). Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science, 369(6505), 1255–1260.

Carvalho, I. (2020, 01, abr.). Contenção. Quais são as medidas adotadas por cada estado brasileiro contra o coronavírus. Brasil de Fato, São Paulo (SP) [Internet]. Recuperado em 22 de novembro de 2022, de https://www.brasildefato.com.br/2020/04/01/quais-sao-as-medidas-adotadas-por-cada-estado-brasileiro-contra-o-coronavirus.

G1. (2021, 22, jan.). Bem-estar. Coronavírus. Brasil volta a ter média móvel de mais de 1 mil mortos por covid por dia; alta no AM preocupa [Internet]. Recuperado em 22 de janeiro de 2021, de https://g1.globo.com/bemestar/coronavirus/noticia/2021/01/21/casos-e-mortes-por-coronavirus-no-brasil-em-21-de-janeiro-segundo-consorcio-de-veiculos-de-imprensa.ghtml.

Hallal, P. C., Hartwig, F. P., Horta, B. L., Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., et al. (2020). SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Glob Health, 8. e1390-e1398.

Johns Hopkins University & Medicine. (2023, 04, jan.). Coronavírus resource center. Maps & trends: mortality analyses. Recuperado em 04 de janeiro de 2023, de https://coronavirus.jhu.edu/data/mortality.

Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020). Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science, 368(6493), 860-868.

Koo, J. R., Cook, A. R., Park, M., Sun, Y., Sun, H., Lim, J. T., et al. (2020). Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis., 20(6), 678-688.

Kraemer, M. U. G., Yang, C-H., Gutierrez, B., WU, C-H., Klein, B., Pigott, DM., et al. (2020). The effect of human mobility and control measures on the covid-19 epidemic in China. Science, 368(6490), 493-497.

Lewnard, J. A., & Lo, N. C. (2020). Scientific and ethical basis for social-distancing interventions against covid-19. Lancet Infect Dis., 20(6), 631-633.

Orellana, J. D. Y., Cunha, G. M., Marrero, L., Horta, B. L., & Leite, I. C. (2020). Explosão da mortalidade no epicentro amazônico da epidemia de covid-19. Cadernos de Saúde Pública, 36(7). e00120020.

Organização Pan-americana da saúde (OPAS). Organização Mundial da Saúde (OMS). (2020). Histórico da pandemia de covid-19. Recuperado em 06 de janeiro de 2023, de https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19.

Ranzani, O. T., Bastos, L. S. L., Gelli, J. G. M., Marchesi, J. F., Baião, F., Hamacher, S., et al. (2021, 15, jan.). Characterisation of the first 250.000 hospital admissions for covid-19 in Brazil: a retrospective analysis of nationwide data [Internet]. Lancet, 9(4), 407-418.

Stein, R. A. (2020). Covid-19 and Rationally Layered Social Distancing. Int J Clin Pract., 74. e13501.

Walker, P. G. T., Whittaker, C., Watson, O., Baguelin, M., Ainslie, K. E. C., Bhatia. S., et al. (2020, 26, mar.). Report 12: the global impact of covid-19 and strategies for mitigation and suppression. Imperial College covid-19 Response Team. 26 March. 1-28. Recuperado em 08 de janeiro de 2023, de https://spiral.imperial.ac.uk/bitstream/10044/1/77735/10/2020-03-26-COVID19-Report-12.pdf.

World Health Organization (WHO). (2023, 04, jan.). WHO Coronavirus (COVID-19) Dashboard. Recuperado em 04 de janeiro de 2023, de https://covid19.who.int/.

Published

2024-12-04

How to Cite

Initial containment plan and non-pharmacological measures adopted by Brazilian states at the beginning of the covid-19 pandemic. (2024). Revista De Estudios Brasileños, 11(23), 185-200. https://doi.org/10.14201/reb20241123185200